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Abstract
Background
People with dementia living in care homes often experience clinically significant agitation;
however, little is known about its economic impact.
Objective
To calculate the cost of agitation in people with dementia living in care homes.
Methods
We used the baseline data from 1,424 residents with dementia living in care homes (part of
Managing Agitation and Raising QUality of lifE in dementia (MARQUE) study) that had
Cohen-Mansfield Agitation Inventory (CMAI) scores recorded. We investigated the relation-
ship between residents’ health and social care costs and severity of agitation based on the
CMAI total score. In addition, we assessed resource utilisation and compared costs of resi-
dents with and without clinically significant symptoms of agitation using the CMAI over and
above the cost of the care home.
Results
Agitation defined by the CMAI was a significant predictor of costs. On average, a one-point
increase in the CMAI will lead to a 0.5 percentage points (cost ratio 1.005, 95%CI 1.001 to
1.010) increase in the annual costs. The excess annual cost associated with agitation per
resident with dementia was £1,125.35. This suggests that, on average, agitation accounts for
44% of the annual health and social care costs of dementia in people living in care homes.
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Conclusion
Agitation in people with dementia living in care homes contributes significantly to the overall
costs increasing as the level of agitation increases. Residents with the highest level of agita-
tion cost nearly twice as much as those with the lowest levels of agitation, suggesting that
effective strategies to reduce agitation are likely to be cost-effective in this setting.
Introduction
It is estimated that 46.8 million people worldwide were living with dementia in 2015 with a
total cost to society of US$818 billion. Given current population trends and that prevalence of
dementia increases with age, the number of people with dementia worldwide is projected to
triple to 131.5 million in 2050 [1].
In the UK, the estimated number of people living with dementia was over 800,000 in 2014
with a total cost to society of £26.3 billion. It is projected that the number of people with
dementia in the UK will be over 1 million by 2025 and over 2 million by 2051 [2].
Dementia is characterised by progressive cognitive disability, a high prevalence of neuro-
psychiatric symptoms such as agitation, depression and psychosis, reduced quality of life,
increased caregiver burden and costs of care [3, 4]. Symptoms of agitation comprise restless-
ness, pacing, shouting and verbal and physical aggression [5].
Agitation contributes to breakdown of care at home leading to care home placement [6]
and this increases costs of care [7, 8]. It is estimated that more than half of people with demen-
tia living in care homes have symptoms of agitation [9–12].
Although agitation in people living with dementia in their own homes is known to increase
demand on health and social care services [13] and add to the family carer stress [14, 15], little
is known about its economic impact [7]. A recent study [16] assessing the additional societal
cost of care of agitation (based on Neuropsychiatric Inventory Questionnaire (NPI-Q) associ-
ated with dementia in 8 European countries, including England (mixed community and insti-
tutional long-term care) concluded that 53% of the total cost (total monthly mean cost
differences due to agitation, 561€) was attributable to the institutional care cost and this was
driven by higher outpatient cost.
We therefore aimed to compare the costs for care home residents with different levels of
agitation measured by the Cohen-Mansfield Agitation Inventory (CMAI). In a sensitivity anal-
ysis we repeated the analysis using the Neuropsychiatric Inventory (NPI) agitation scale. In
addition, we calculated the cost of agitation (over and above the cost of the care home) in resi-
dents with and without clinically significant symptoms of agitation using the CMAI as well as
the excess costs associated with agitation.
Methods
Participants / Data source and study population
This study is part of the Managing Agitation and Raising QUality of lifE in dementia (MAR-
QUE) study.
We have reported the recruitment strategy in detail elsewhere [12].
Care home managers agreed to care home inclusion, provided a staff list and identified resi-
dents with clinical diagnosis of dementia. For residents without a dementia diagnosis, managers
completed the Noticeable Problems Checklist (NPC) [15, 17] to identify probable dementia.
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The NPC is a six-item questionnaire covering memory, basic self-care, orientation, naming
familiar people and ability to follow conversations, which has been used by non-clinicians and
which has been validated against clinical diagnosis. Eligible participants were all residents with
an existing dementia diagnosis or those who screened positive for dementia, and their family
and care home staff.
Staff asked residents, whom they judged to have decisional competence for consent, if
researchers could approach them; they were asked for written informed consent to the study.
Consultees were asked to make this decision for residents who lacked capacity in line with the
Mental Capacity Act (2005). For all other residents, the staff tried to contact the next-of-kin
(to participate in family carer interviews) and asked if the researchers could contact them. Par-
ticipating staff and relatives gave written informed consent. A paid carer working closely with
a resident and a family member was asked to rate proxy measures for the resident. Trained
research assistants conducted interviews using semi-structured questionnaires.
Residents with dementia were recruited from personal care (residential) or nursing care
homes across England between 13 January 2014 and 12 December 2015. Both types of care home
provide accommodation, meals and help with personal care needs from staff 24 hours a day;
however, nursing care homes also have registered nurses on duty at all times who can provide
care for people with more complex needs and those who need regular nursing interventions.
Measures
We report the ratings provided by interviewing staff from the following questionnaires.
Agitation. Cohen-Mansfield Agitation Inventory (CMAI) is a caregivers’ rating question-
naire consisting of 29 agitated behaviours, each rated on a 7-point scale of frequency with
which they manifest physically aggressive, physically non-aggressive and verbally agitated
behaviours with 1 meaning “never” and 7 meaning “several times per hour”. CMAI systemati-
cally assesses agitation in people with dementia with construct validity and reliability to be
used in care homes [4, 18]. A total CMAI score is obtained by summing all the individual
items, giving a range from 29 to 203. A total score of>45 is usually regarded as clinically sig-
nificant agitation [19].
The Neuropsychiatric Inventory (NPI) assesses dementia-related behavioural symptoms
examining 12 domains of behavioural functioning including agitation [20, 21]. Behaviours are
rated in terms of frequency and severity and the product of these forms a score for each
domain. Each domain scores between 0 and 12 giving nine possible values (0, 1, 2, 3, 4, 6, 8, 9,
12), including no symptoms (= 0) with higher scores meaning increasing severity (NPI agita-
tion score). A score of�4 in any domain is usually regarded as clinically significant [22] A
summed score (total NPI score) can also be calculated for total neuropsychiatric symptoms.
Healthcare resource use and costs. Client Service Receipt Inventory (CSRI) [23]: we col-
lected health care resources for the previous 4 months from a detailed resource use question-
naire, amended for use with older people in care homes.
This incorporated information on health and social care service use: primary care, commu-
nity health or emergency services contacts (e.g., general practitioner (GP), practice nurse, spe-
cialist nurse, night nurse, and community psychiatric/ mental health team), accident and
emergency attendances, outpatient contacts, inpatient admissions, social care contacts (e.g.,
social worker, extra carer), community based services contacts (e.g., chiropodist, optician, den-
tist), other professionals contacts (e.g., geriatrician, neurologist, psychiatrist).
All recorded medical prescriptions were aggregated for each resident, with the number of
individual doses prescribed. Net ingredient costs per dose, based on the electronic British
Cost of agitation in people with dementia living in care homes
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National Formulary (BNF) [24] and National Health Service (NHS) Electronic Drug Tariff
[25] were applied to these dose records, in order to arrive at a total cost of prescriptions issued.
We included the NHS and personal and social services perspective in our costing analysis
as it is the recommended costing in economic evaluations in the UK [26].
Costs were estimated by multiplying the number of units used for each relevant resource
factor with the corresponding unit cost (S1 Table) from available sources [27, 28] at 2014/15
UK pounds (£).
Four-month costs were estimated for each resident by adding up total primary care, acci-
dent and emergency, outpatient, inpatient, social care and community services, other medical
professional contacts and prescriptions costs.
The 4-month costs were multiplied by 3 to create annual (12-month) figures.
Analysis
Descriptive data are presented as means and standard deviations (SD) and, where appropriate,
median and interquartile range (IQR) for continuous outcomes and numbers and percentages
(%) for categorical outcomes.
We calculated annual mean costs by CMAI scores (�45 and>45). We also considered the
relationship between annual total costs and continuous CMAI total scores. The cost data was
highly skewed and therefore we used a generalised linear model (GLM). We considered GLM
models with different link functions and distributions and chose the gamma family with loga-
rithmic link based on graphical inspection of the residuals and the Akaike information crite-
rion [29]. We present the exponential of the GLM model coefficients in the form of a cost
ratio.
The dependent variable was the total costs and the independent variable the measure of agi-
tation (CMAI total scores). We adjusted for demographic characteristics and other potential
confounders that may influence the extent to which healthcare resources are used by this pop-
ulation. Covariates included in the model were age, sex, dementia severity (Clinical Dementia
Rating (CDR score)) and care home type ((nursing, residential care or both, dementia regis-
tered (registered to care for people with dementia) or dementia specialist (have a dedicated
dementia specialist and carers specially trained to provide tailored dementia care)).
Similar analyses with agitation defined by the total NPI scores in place of CMAI scores
were conducted.
Analyses were performed using Stata version 14.1[30].
Excess costs associated with agitation
We combined the adjusted annual costs per resident and percentages of residents at different
levels of agitation based on CMAI score to calculate the annual expected costs per resident
with dementia. We then subtracted the adjusted annual costs per residents with no clinical sig-
nificant agitation (CMAI score�45) to estimate the mean excess costs associated with
agitation.
Results
Demographic characteristics
1,489 care home residents with dementia were recruited to the study [12] (S1 File). Of the
1,483 residents with baseline data available, 1,424 residents had CMAI scores recorded; 40% of
residents had CMAI scores>45 indicating clinically significant symptoms.
Cost of agitation in people with dementia living in care homes
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Demographic characteristics of residents with and without clinically significant agitation
are presented in Table 1. The groups are similar in terms of the sociodemographic and other
characteristics studied.
Healthcare resource use and costs
The unadjusted annual mean costs per resident with CMAI scores�45 and>45 were
£2,410.21 (95% CI £2,158.74 to £2,661.67) and £2,800.66 (95%CI £2,451.74 to £3,149.58),
respectively. The total costs in both groups was similar and was driven by healthcare resource
utilisation at different settings except social care contacts, and prescriptions. The difference in
costs between groups was not statistically significant (Table 2).
Table 1. Demographic characteristics by CMAI scores.
Characteristics CMAI�45
(n = 855)
N (%) or otherwise stated
CMAI >45
(n = 569)
N (%) or otherwise stated
p-value
Sex Male 246 (29%) 195 (34%) 0.03
Female 609 (71%) 374 (66%)
Mean age (years) 85.5 (8.4) 84.5 (8.5) 0.03
Age category �60 9 (1%) 7 (1%) 0.02
61–70 40 (5%) 33 (6%)
71–80 154 (18%) 112 (20%)
81–90 393 (46%) 274 (48%)
�91 245 (29%) 133 (23%)
Missing 14 (2%) 10 (2%)
Ethnicity White British 763 (89%) 485 (85%) <0.001
White Irish 24 (3%) 19 (3%)
White other 27 (3%) 20 (4%)
Chinese 0 (0%) 2 (0.4%)
Black British, Caribbean, African 18 (2%) 14 (2%)
Asian or Asian British, Indian, Pakistani, Bangladeshi 5 (1%) 8 (1%)
Other 9 (1%) 19 (3%)
Missing 9 (1%) 2 (0.4%)
Care home type Nursing care home 121 (14%) 91 (16%) 0.09
Personal care (residential) home 307 (36%) 220 (39%)
Nursing & personal care home 427 (50%) 258 (45%)
Living in a dementia registered care home 764 (89%) 535 (94%) <0.001
Living in a dementia specialist care home 345 (40%) 273 (48%) <0.001
Dementia severity Very mild 98 (11%) 15 (3%) 0.01
Mild 203 (24%) 102 (18%)
Moderate 255 (30%) 212 (37%)
Severe 296 (35%) 239 (42%)
Missing 3 (<1%) 1 (<1%)
CMAI scores Mean (SD) 35 (5) 64 (17) <0.001
Median (IQR) 34 (30, 39) 60 (51, 73)
NPI agitation scores 324 (38%) 481 (85%)
Mean (SD) 3 (2) 4 (3) 0.4
Median (IQR) 3 (1, 4) 4 (3, 8)
CMAI = Cohen-Mansfield Agitation Inventory; NPI = Neuropsychiatric Inventory scale; SD = standard deviation; IQR = interquartile range; N = number.
https://doi.org/10.1371/journal.pone.0211953.t001
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The results of the regression model are presented in Table 3. Agitation defined by CMAI
scores was a significant predictor of annual mean costs indicating that, on average, a one-point
increase in the CMAI total scores will lead to a 0.5 percentage points (cost ratio 1.005, 95%CI
1.001 to 1.010) increase in the annual costs.
In addition, living in residential care homes (without taking into account the care home
costs) was a significant predictor of additional annual costs (cost ratio 1.403; 95%CI 1.088 to
1.810).
Table 2. Annual mean costs per resident by CMAI scores (£, 2014/15 UK).
Resource use CMAI�45 CMAI >45 Difference
N Mean (95%CI) N Mean (95%CI) Mean (95%CI)
Overnight inpatient stay 64 £10,761.23
(£9,808.52 to £11,713.95)
52 £11,054.83
(£9,904.20 to £12,205.46)
£293.60
(-£1,170.95 to £1,758.15)
Outpatient contacts 182 £ 431.04
(£393.91 to £468.18)
116 £398.33
(£363.70 to £432.96)
-£32.72
(-£86.64 to £21.21)
Accident and Emergency contacts 82 £ 439.46
(£408.87 o £470.05)
78 £467.08
(£427.03 to £507.12)
£27.61
(-£22.08 to £77.31)
Primary care, community health or emergency contacts 690 £765.88
(£685.28 to £846.47)
483 £802.76
(£699.24 to £906.29)
£36.89
(-£92.52 to £166.29)
Social care contacts 120 £166.43
(£127.17 to £205.68)
79 £274.52
(£56.36 to £492.68)
£ 108.09
(-£73.53 to £289.72)
Community based service contacts 521 £ 420.24
(£350.47 to £490.00)
354 £431.43
(£358.60 to £504.26)
£11.19
(-£92.44 to £114.83)
Other medical professionals contacts 201 £1,110.43
(£846.75 to £1,374.10)
159 £1,092.87
(£804.97 to £1,380.77)
-£17.56
(-£407.98 to £372.86)
Prescriptions 838 £312.81
(£276.23 to £349.39)
547 £360.82
(£316.66 to £404.99)
£48.01
(-£9.59 to £105.62)
Total cost 853 £2,410.21
(£2,158.74 to £2,661.67)
568 £2,800.66
(£2,451.74 to £3,149.58)
£ 390.45
(-£28.72 to £809.63)
CMAI = Cohen-Mansfield Agitation Inventory; CI = confidence interval; N = number
https://doi.org/10.1371/journal.pone.0211953.t002
Table 3. Impact of agitation (by CMAI scores) and other factors on annual mean costs (£, 2014/15 UK),
N = 1,396.
Covariates Cost ratio (95% CI)
CMAI scores 1.005 (1.001–1.010)
Age (years) 1.002 (0.991–1.013)
Female 0.942 (0.785–1.131)
Dementia severity
Very mild Reference
Mild 0.786 (0.561–1.101)
Moderate 0.888 (0.641–1.231)
Severe 0.915 (0.663–1.261)
Care home type
Nursing care home Reference
Personal care (residential) home 1.403 (1.088–1.810)
Nursing & personal care home 1.180 (0.924–1.508)
Dementia registered care home 0.802 (0.593–1.086)
Dementia specialist care home 1.027 (0.865–1.220)
CMAI = Cohen-Mansfield Agitation Inventory; CI = confidence interval; N = number
https://doi.org/10.1371/journal.pone.0211953.t003
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The CMAI scores in our sample ranged from 29 to 137. We calculated the annual mean
costs with levels of CMAI scores that range from 29 to 139 for all observations at intervals of
10 (other variables held at their observed values).
With other variables at their observed values and CMAI scores held at 29 for all observa-
tions, the annual mean cost was £2,321.69 (95%CI £2,057.76 to £2,585.63); when CMAI
scores = 139 the annual mean cost was £4,218.18 (95%CI £2,394.01 to £6,042.34) (S2 Table).
Sensitivity analyses with agitation defined by total NPI scores (used as a linear term rather
than categorical indicators) showed a non-significant increase of 2.8 percentage point (cost
ratio 1.028; 95%CI 0.993 to 1.065) in annual costs for one-point increase in the total NPI scores
(S3 Table).
Excess costs associated with agitation
The adjusted annual expected cost per resident with dementia based on the percentage with
each CMAI score was £2,564.39. The adjusted annual expected cost of residents with no clini-
cal significant agitation was £1,439.04 (S4 Table). This results in an excess annual cost of agita-
tion of £1,125.35 accounting for 44% of the health and social care costs of dementia in care
homes.
Discussion
Main findings
This is the first study to consider the cost of agitation in residents living in care homes, using
data from MARQUE cross-sectional study, the biggest care home study to date. Previously the
cost of agitation has been considered in the main because it contributed to admission to care
homes. We found a significant increase in healthcare costs as the CMAI scores increase (cost
ratio 1.005, 95%CI 1.001 to 1.010).
Although, scoring the answers on the CMAI scale may not indicate a clinical difference
between consecutive CMAI scores (e.g., 49 and 50), there are other factors that may affect the
CMAI score and contribute to the incremental cost. One study [31] reported that for every
1-point increase on the CMAI, there is a 3% increase in the likelihood of caregivers rating
patient pain (p = 0.049); another study supports this finding [32]. The management of pain
could conduct to the difference in costs.
In contrast, the accompanying paper of this study [12] reported that staff did not consider
that agitation might be a manifestation of pain. Therefore, other factors could have had an
impact on the cost. Higher agitation levels were significantly associated with lower staff and
family ratings of the resident’s quality of life, and with prescription of antipsychotics and hyp-
notics: agitation was associated with lower quality of life (regression coefficient (rc) = −0.53,
95%CI = −0.61 to −0.46) and antipsychotic use (rc = 6.45, 95%CI = 3.98 to 8.91).
On average, agitation accounts for 44% of the annual health and social care costs of demen-
tia in people living in care homes. Sensitivity analyses with agitation defined by NPI scores
showed an increase in annual mean costs, although not statistically significant.
People with dementia and agitation are more likely to be admitted to care homes as the
family carer becomes unable to look after them. According to the PayingForCare report for
2016/17 [33], people are expected to pay on average more for nursing care homes than residen-
tial care homes per year in the UK (£43,700 vs £31,200) and that depends whether they need
nursing care or not. Our study shows that even within residential care homes which provide
24 hour care, residents with agitation use more health and social care resources as they require
additional nursing or dementia care to their personal care. Although nursing care homes are
more expensive than residential care homes, overall cost may be similar for both types of care
Cost of agitation in people with dementia living in care homes
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homes due to additional resource utilisation in residential care homes. However, this addi-
tional resource utilisation is paid for by the health services, whereas up-front costs for nursing
care home placements are paid for by the individual and/or social care.
Strengths and weaknesses
This is the largest study of residents with dementia-related agitation in care homes to date. It
covered varied care homes throughout England. The dataset provided detailed information on
residents’ characteristics, including severity of dementia as well as use of healthcare services.
The information is relatively recently collected which shows current practice in healthcare pro-
vided for people with dementia.
Our analysis showed that agitation (using CMAI scale) is associated with increase in health-
care costs in people with dementia. However, this is an observational study and therefore, this
may not be causative and there could be other unobserved confounding factors that are con-
tributing to both costs and agitation, although we have controlled for demographic features
and dementia severity. We did not include the costs of family care although families continue
to contribute when members of the family move to a care home; these data were not collected.
We used the CMAI total score in our analysis and have not controlled for the impact of par-
ticular behaviours/clusters of behaviours (e.g., aggressive vs non-aggressive) on cost as well as
associated comorbidities. CMAI scores based on particular types of behaviours might be asso-
ciated with higher costs. However, our study did not aim to look into particular behaviours on
the CMAI scale but on the CMAI score as a total.
Comparison with other studies
To our knowledge, no previous large study has assessed the impact of dementia-related agita-
tion on health and social care costs in a care home setting. There are two studies that assessed
the costs of behavioural symptoms particularly in Alzheimer’s disease–AD–(type of dementia
that causes problems with memory, thinking and behaviour) in the UK, using the NPI agita-
tion scale in community or mixed community and care home setting. Morris et al. [8] con-
cluded that, on average, agitation symptoms accounted for 12% of the health and social care
costs of AD. Gustavsson et al. [34] studied people residing at home or in care homes and
showed no significant effect of agitation on costs for the residents with AD in care homes in
the UK, Spain and Sweden (N = 70–118). In the United States only, one point increase in the
NPI-severity had significant effect on costs (increase by 1.6%).
Similarly, our secondary analyses using total NPI scores found a non-significant increase in
health care costs with agitation severity possibly because of the much narrower definition of
agitation used in the NPI compared to CMAI.
Implications
Health and social care costs in people with dementia increase with level of agitation. Invest-
ment should be made into developing interventions to reduce agitation given not only the
potential positive impact on quality of life of residents, care home staff and carers; these are
likely to represent value for money if they reduce the consumption of healthcare resources. A
systematic review [35] of the clinical effectiveness and cost-effectiveness of non-pharmacologi-
cal interventions for reducing agitation in adults with dementia evaluated 11 interventions
with impact on the CMAI. The incremental cost per unit reduction in CMAI score ranged
from £162 to £3,480 for activities, £4 for music therapy, from £24 to £143 for sensory interven-
tions and from £6 to £62 for training and supervising paid caregivers in person-centred care or
communication skills, behavioural management training or dementia care mapping.
Cost of agitation in people with dementia living in care homes
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